| Valerie Moser, | |
|
235 W Lancaster Ave, Devon, PA 19333-1560 | |
| (484) 654-9000 | |
| Not Available |
| Full Name | Valerie Moser |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 235 W Lancaster Ave, Devon, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467237685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN095541L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Moser, 235 W Lancaster Ave, Devon, PA 19333-1560 Ph: (484) 654-9000 | Valerie Moser, 235 W Lancaster Ave, Devon, PA 19333-1560 Ph: (484) 654-9000 |
News Archive
The UK's population is ageing and with it comes an increased risk of developing age-related diseases such as Parkinson's. About 70% of dopamine producing brain cells will have been lost by the time a sufferer visits the doctor, with symptoms that include difficulties with movement and a resting tremor. A progressive neurodegenerative disease, Parkinson's affects about 120,000 people in the UK.
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.
Thirty percent of the home health care workers' compensation cases managed by Total Medical Solutions (TMS) were discharged prior to the "order-end date," the last date the physician had anticipated that services would be required.
GENETICALLY engineered bacteria could become the latest weapons against cancer, Cancer Research UK scientists suggest in a study published today 22nd April 2004.
Tumours that have low concentrations of oxygen (hypoxia) are resistant to radiotherapy. A drug called nimorazole (a hypoxia radiosensitiser) can improve the outcome of radiotherapy for patients with these types of tumours. However, at the moment there is no way to identify people with tumours that lack oxygen, who need this additional drug treatment, from those that only need radiotherapy.
› Verified 5 days ago
Lorraine Yvonne Zeno, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 484-551-3366 | |
Ajee Green, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 484-551-3366 | |
Marisella Campos-smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 484-654-9977 Fax: 484-325-6219 | |
Melissa Eileen Butler, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 484-654-3085 | |
Angela Lee Hudick, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 484-654-9937 Fax: 484-252-2537 | |
Matthew Mccarry, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 855-740-1921 | |
Amber Elizabeth Graves, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 235 W Lancaster Ave, Devon, PA 19333 Phone: 484-551-3366 |